Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 487.70
+6.50 (1.35%)
Feb 27, 2026, 3:39 PM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 108.35 billion as of February 27, 2026. Its market cap has decreased by -38.79% in one year.
Market Cap
108.35B
Enterprise Value
132.32B
Revenue
27.89B
Ranking
n/a
PE Ratio
27.19
Stock Price
487.70
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 108.35B, an increase of 1,742.69%. That is a compound annual growth rate of 10.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 108.53B | -11.86% |
| Dec 30, 2025 | 123.14B | -30.43% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.06T |
| Genmab | 112.95B |
| ALK-Abelló | 46.53B |
| Demant | 41.23B |
| H. Lundbeck | 37.23B |
| Zealand Pharma | 25.42B |
| Ambu A/S | 21.13B |
| Bavarian Nordic | 15.25B |